🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare the efficacy and safety of in...
Status
Not Yet Recruiting
Location
ThirdXiangyaHCSU
Start Date
2026-05-15
Trial ID
NCT07643350
Treatments Being Tested
Efficacy and safety of Benmelstobart combined with Anlotinib and oral metro...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-30
Trial ID
NCT07489300
Treatments Being Tested
A multicenter, randomized, controlled, open-label, Phase II/III clinical tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-05
Trial ID
NCT07535567
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This prospective, single-arm, multicenter Phase II clinical trial aims to e...
Status
Not Yet Recruiting
Location
Nanfang Hospital of Southern Medical University
Start Date
2026-04-20
Trial ID
NCT07537777
Treatments Being Tested
A total of 66 patients were enrolled in this exploratory study and randomly...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-20
Trial ID
NCT06978153
This study is aimed to evaluate the efficacy and safety of the Garsorasib c...
Status
Not Yet Recruiting
Location
Sun Yat-sen University
Start Date
2025-12-23
Trial ID
NCT07294261
To explore the Objective Response Rate (ORR) of Benmelstobart combined with...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2026-05-01
Trial ID
NCT07510594
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of b...
Status
Not Yet Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-15
Trial ID
NCT06931145
Treatments Being Tested
There is currently no standard first-line treatment for stage PPGL, and the...
Status
Not Yet Recruiting
Location
Cancer Center, Sun Yat-sen University
Start Date
2025-05-01
Trial ID
NCT06429397
Treatments Being Tested